← All companies
REGENERON PHARMACEUTICALS, INC.
REGN - Company ID 0000872589
Market cap$56.80 B
Rank#291
Filings985
The table below shows REGENERON PHARMACEUTICALS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.96B | $2.51B | $2.00B | $3.09B | $2.01B | $1.92B |
| Short-term investments | $5.79B | $5.94B | $5.47B | $5.26B | $7.78B | $7.89B |
| Receivables | $5.73B | $5.69B | $5.61B | $5.56B | $6.11B | $5.72B |
| Inventory | $3.10B | $3.25B | $3.21B | $3.19B | $3.02B | $2.87B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.